Obstruction of bile duct
ICD-10 K83.1 is a billable code used to indicate a diagnosis of obstruction of bile duct.
Obstruction of the bile duct is a condition characterized by the blockage of the bile duct system, which can lead to the accumulation of bile in the liver and subsequent liver damage. The bile ducts are part of the biliary system, which includes the gallbladder, liver, and pancreas. Common causes of bile duct obstruction include gallstones, tumors, strictures, and inflammation. Clinically, patients may present with jaundice, dark urine, pale stools, pruritus, and abdominal pain, particularly in the right upper quadrant. The progression of the disease can lead to cholangitis, pancreatitis, or liver failure if not addressed promptly. Diagnostic considerations involve imaging studies such as ultrasound, CT scans, or MRCP to visualize the biliary tree and identify the site and cause of obstruction. Laboratory tests may reveal elevated liver enzymes, bilirubin levels, and alkaline phosphatase. Early diagnosis and intervention are crucial to prevent complications and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K83.1 covers conditions specifically related to the obstruction of the bile duct, including those caused by gallstones, tumors, strictures, or external compression. It is important to differentiate these from other biliary conditions such as cholangitis or biliary fistula.
K83.1 should be used when there is a confirmed diagnosis of bile duct obstruction. If the obstruction is due to a specific cause, such as a gallstone, additional codes may be required to specify the underlying condition.
Documentation should include clinical findings, imaging results that confirm the obstruction, laboratory test results indicating liver function impairment, and any treatment plans or interventions performed.
